Connective Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Connective Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.07M	Sell	6,736 -16,512	-71%	-$2.23M	0.75%	21
2026 Q1	$2.97M	Buy	23,248 +15,235	+190%	+$1.9M	2.45%	16
2025 Q4	$977K	Buy	+8,013	New	+$919K	0.57%	19
2024 Q1	–	Sell	-22,080	Closed	-$1.97M	–	86
2023 Q4	$1.97M	Buy	+22,080	New	+$1.64M	1.64%	15
2023 Q3	–	Sell	-18,896	Closed	-$1.57M	–	40
2023 Q2	$1.57M	Buy	18,896 +8,227	+77%	+$688K	1.83%	17
2023 Q1	$813K	Buy	+10,669	New	+$885K	1.2%	15

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Connective Capital Management's XBI Position: Q2 2026 in Review

Connective Capital Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 71% in Q2 2026, selling an estimated $2.23M and leaving 6,736 shares worth $1.07M. The position accounts for 0.75% of the portfolio, ranked #21.

Connective Capital Management first reported a position in XBI in Q1 2023 and has held it in 6 quarters since. The position peaked at $2.97M in Q1 2026. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Connective Capital Management held 6,736 shares of State Street SPDR S&P Biotech ETF worth $1.07M as of Q2 2026.
Connective Capital Management sold 16,512 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $2.23M.
State Street SPDR S&P Biotech ETF made up 0.75% of Connective Capital Management's portfolio in Q2 2026, its #21 holding.
Connective Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 6 quarters since.
Connective Capital Management's State Street SPDR S&P Biotech ETF position peaked at $2.97M in Q1 2026.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Connective Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.